Literature DB >> 20433360

Pharmacokinetics of the treatment switch from efavirenz to nevirapine.

Jean-Jacques Parienti, Gilles Peytavin, Véronique Reliquet, Renaud Verdon, Antoine Coquerel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20433360     DOI： 10.1086/652718

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  2 in total

Review 1.  A systematic review of the impact of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilization.

Authors:  Marwan M Azar; Sandra A Springer; Jaimie P Meyer; Frederick L Altice
Journal:  Drug Alcohol Depend       Date:  2010-08-11       Impact factor: 4.492

2.  Use of in vitro to in vivo extrapolation to predict the optimal strategy for patients switching from efavirenz to maraviroc or nevirapine.

Authors:  Alessandro Schipani; David Back; Andrew Owen; Gerry Davies; Saye Khoo; Marco Siccardi
Journal:  Clin Pharmacokinet       Date:  2015-01       Impact factor: 5.577
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.